Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Correlation between serum PSA and testosterone (T) kinetics in patients (pts) with biochemically relapsed prostate cancer (BRPC) (M0), after local treatment (tx), treated with intermittent androgen ...

A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...

Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...

Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

Patients undergoing robotic-assisted laparoscopic radical prostatectomy (RALRP) are more likely that those undergoing open radical prostatectomy (ORP) to have benign glandular tissue at the surgical ...

Delray Medical Center is the first hospital in Palm Beach and Broward Counties to offer the AquaBeam Robotic System Aquablation therapy for treatment of lower urinary tract symptoms (LUTS) and benign ...

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...